Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

397 jobs
Number of planned job losses
Job loss
Announcement Date
23 January 2007
Employment effect (start)
1 February 2007
Foreseen end date
31 December 2008

Description

Pfizer France, the French subsidiary of US pharmaceutical company Pfizer Inc, announced on 23 January 2007 to the works council that 504 jobs will be cut in France between February 2007 and December 2008.

The redundancies will affect medical representatives, the company's headquarters in Paris and a research laboratory in Amboise, which is to be closed down. The decision is part of the company's plans to cut 10,000 jobs worldwide, or about 10% of its workforce, by the end of 2008. The company's works council complained in a press release that Pfizer employees are losing their jobs for the sake of profits in a sector that is no longer taking on new staff and employees have reacted angrily to the company's restructuring plan. Despite competition from generic drug manufacturers over key medications, Pfizer's results remain extremely strong, with a profit of 15 billion USD, excluding extraordinary items being recorded in 2006. Pfizer France announced on 9 May 2007 that after discussions with the trade unions it will finally cut 397 jobs in France instead of the 504 initially announced.


Sources

  • 23 January 2007: AFP
  • 22 January 2007: Les Echos
  • 24 January 2007: Le Figaro
  • 24 January 2007: AFP

Citation

Eurofound (2007), Pfizer France, Internal restructuring in France, factsheet number 64819, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64819.